ArticleHeliyon2024

Evaluation of the efficacy and safety of ramucirumab combined with nab-paclitaxel, lobaplatin, and S-1 in neoadjuvant and conversion therapy for advanced gastric cancer: A study protocol of prospective single-center, randomized controlled and open label clinical trial (RNPLS-01).

Juan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.